Hormonal treatment of mammary carcinoma with Progynon-Depot and Depostat

Acta Radiologica: Therapy, Physics, Biology
G Notter, G Berndt

Abstract

The results of combined treatment with 90 mg estradiol valerianate and 300 mg 17-alpha-hydroxy-19-norprogesterone-capronate (SH 834) (3 ml once a week i.m.) in 117 cases with disseminated or inoperable mammary carcinoma are reported. Objective remissions of 3 to 36 months were obtained in 48 patients. Soft tissue, lung and pleura metastases responded more favourably than bone metastases. Liver and brain metastases were unaffected.

References

Nov 27, 1970·Deutsche medizinische Wochenschrift·G Berndt, H S Stender
Dec 1, 1965·Cancer·B J Kennedy
Jan 1, 1959·Cancer·H M LEMON
Jun 22, 1964·JAMA : the Journal of the American Medical Association·I S GOLDENBERG
Sep 1, 1964·Cancer·B J KENNEDY, I E FORTUNY
Sep 1, 1965·American Journal of Surgery·B J KENNEDY, L FRENCH
Apr 1, 1960·American Journal of Surgery·O H PEARSON, B S RAY
Mar 15, 1962·Proceedings of the National Academy of Sciences of the United States of America·C HUGGINSS MORII
Apr 1, 1962·The Surgical Clinics of North America·B S RAY, O H PEARSON

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

© 2022 Meta ULC. All rights reserved